List of Excipients in API calcifediol
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing calcifediol
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | ALCOHOL | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | BUTYLATED HYDROXYTOLUENE | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | CARRAGEENAN | 2034-03-14 |
| OPKO Pharmaceuticals LLC | RAYALDEE | calcifediol | 70301-1001 | FD&C BLUE NO. 1 | 2034-03-14 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for calcifediol
Excipient focus: ALCOHOL
calcifediol drug variants containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: BUTYLATED HYDROXYTOLUENE
calcifediol drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARRAGEENAN
calcifediol drug variants containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing CARRAGEENAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FD&C BLUE NO. 1
calcifediol drug variants containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing FD&C BLUE NO. 1
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL MONO- AND DIPALMITOSTEARATE
calcifediol drug variants containing GLYCERYL MONO- AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing GLYCERYL MONO- AND DIPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CORN STARCH
calcifediol drug variants containing HYDROXYPROPYL CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing HYDROXYPROPYL CORN STARCH
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
calcifediol drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: LAUROYL PEG-32 GLYCERIDES
calcifediol drug variants containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing LAUROYL PEG-32 GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
calcifediol drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
calcifediol drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PARAFFIN
calcifediol drug variants containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing PARAFFIN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, DIBASIC
calcifediol drug variants containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SODIUM PHOSPHATE, DIBASIC
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN
calcifediol drug variants containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SORBITAN
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
calcifediol drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
calcifediol drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
calcifediol drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| OPKO Pharmaceuticals LLC | calcifediol | 70301-1001 |
| >Company | >Ingredient | >NDC |
calcifediol drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch